User Fee-Funded Staff Would Drop In FY 2026 US FDA Budget

The reductions across medical product programs in the agency’s budget request include hundreds of positions funded by user fees, which may foreshadow its upcoming user fee restructuring strategy.

The reduction of user-fee funded positions in the FDA's FY 2026 budget request could foreshadow its approach to the upcoming user fee program reauthorizations. (Shutterstock)

More from US FDA

More from Pathways & Standards